{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:40:05Z","timestamp":1793968805196,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health, USA","doi-asserted-by":"crossref","award":["5-R01-HL 107904-13"],"award-info":[{"award-number":["5-R01-HL 107904-13"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39062-w","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T02:35:12Z","timestamp":1770604512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ex vivo HNSCC clinical studies using saliva and antiviral or antibacterial chewing gums reveal reduction in carcinogenic microbes"],"prefix":"10.1038","volume":"16","author":[{"given":"Henry","family":"Daniell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Wakade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smruti","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj K.","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri S.","family":"Srivatsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s M.","family":"Bur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufi M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilene B.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"39062_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/pbi.13556","volume":"19","author":"H Daniell","year":"2021","unstructured":"Daniell, H. et al. Green giant-a tiny chloroplast genome with mighty power to produce high-value proteins: History and phylogeny. Plant. Biotechnol. J. 19, 430\u2013447 (2021).","journal-title":"Plant. Biotechnol. J."},{"key":"39062_CR2","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41587-023-01899-1","volume":"41","author":"H Daniell","year":"2023","unstructured":"Daniell, H., Kulchar, R. J., Herzog, R. W., Kulis, M. & Leong, K. W. Plant cell-based drug delivery enhances affordability of biologics. Nat. Biotechnol. 41, 1186\u20131187 (2023).","journal-title":"Nat. Biotechnol."},{"key":"39062_CR3","doi-asserted-by":"publisher","first-page":"122312","DOI":"10.1016\/j.biomaterials.2023.122312","volume":"302","author":"RJ Kulchar","year":"2023","unstructured":"Kulchar, R. J. et al. Delivery of biologics: Topical administration. Biomaterials 302, 122312 (2023).","journal-title":"Biomaterials"},{"key":"39062_CR4","doi-asserted-by":"publisher","first-page":"126073","DOI":"10.1016\/j.ijbiomac.2023.126073","volume":"249","author":"S Bektas","year":"2023","unstructured":"Bektas, S. & Kaptan, E. Therapeutic potential of lectins in the treatment of breast cancer: A review. Int. J. Biol. Macromol. 249, 126073 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"39062_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ijbiomac.2019.09.119","volume":"142","author":"AK Gautam","year":"2020","unstructured":"Gautam, A. K., Sharma, D., Sharma, J. & Saini, K. C. Legume lectins: Potential use as diagnostics and therapeutics against the cancer. Int. J. Biol. Macromol. 142, 474\u2013483 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"39062_CR6","doi-asserted-by":"publisher","first-page":"121671","DOI":"10.1016\/j.biomaterials.2022.121671","volume":"288","author":"H Daniell","year":"2022","unstructured":"Daniell, H. et al. Debulking different Corona (SARS-CoV-2 delta, omicron, OC43) and influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and transmission. Biomaterials 288, 121671 (2022).","journal-title":"Biomaterials"},{"key":"39062_CR7","doi-asserted-by":"publisher","first-page":"108016","DOI":"10.1016\/j.celrep.2020.108016","volume":"32","author":"YM Liu","year":"2020","unstructured":"Liu, Y. M. et al. A Carbohydrate-Binding protein from the edible lablab beans effectively blocks the infections of influenza viruses and SARS-CoV-2. Cell. Rep. 32, 108016 (2020).","journal-title":"Cell. Rep."},{"key":"39062_CR8","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3390\/pharmaceutics16091234","volume":"16","author":"AN Chernov","year":"2024","unstructured":"Chernov, A. N. et al. Glioblastoma multiforme: sensitivity to antimicrobial peptides LL-37, PG-1 and its combinations with chemotherapy for prediction of overall survival of the patients. Pharmaceutics 16, 1234 (2024).","journal-title":"Pharmaceutics"},{"key":"39062_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1467-7652.2010.00538.x","volume":"9","author":"SB Lee","year":"2011","unstructured":"Lee, S. B., Li, B., Jin, S. & Daniell, H. Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Plant. Biotechnol. J. 9, 100\u2013115 (2011).","journal-title":"Plant. Biotechnol. J."},{"key":"39062_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.biomaterials.2016.07.042","volume":"105","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Topical delivery of low-cost protein drug candidates made in chloroplasts for biofilm disruption and uptake by oral epithelial cells. Biomaterials 105, 156\u2013166 (2016).","journal-title":"Biomaterials"},{"key":"39062_CR11","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/1042819031000079159","volume":"44","author":"FJ Giles","year":"2003","unstructured":"Giles, F. J. et al. A phase III, randomized, double-blind, placebo-controlled, multinational trial of Iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial). Leuk. Lymphoma. 44, 1165\u20131172 (2003).","journal-title":"Leuk. Lymphoma"},{"key":"39062_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.leukres.2003.10.021","volume":"28","author":"FJ Giles","year":"2004","unstructured":"Giles, F. J. et al. A phase III, randomized, double-blind, placebo-controlled, study of Iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. Leuk. Res. 28, 559\u2013565 (2004).","journal-title":"Leuk. Res."},{"key":"39062_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-0714.2011.01094.x","volume":"41","author":"S Elad","year":"2012","unstructured":"Elad, S., Epstein, J. B., Raber-Durlacher, J., Donnelly, P. & Strahilevitz, J. The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: Analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial. J. Oral Pathol. Med. 41, 229\u2013234 (2012).","journal-title":"J. Oral Pathol. Med."},{"key":"39062_CR14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1158\/2767-9764.CRC-23-0002","volume":"3","author":"CJ Paller","year":"2023","unstructured":"Paller, C. J. et al. Phase I trial of intravenous mistletoe extract in advanced cancer. Cancer Res. Commun. 3, 338\u2013346 (2023).","journal-title":"Cancer Res. Commun."},{"key":"39062_CR15","doi-asserted-by":"publisher","first-page":"e0261775","DOI":"10.1371\/journal.pone.0261775","volume":"17","author":"N Teleshova","year":"2022","unstructured":"Teleshova, N. et al. Results of a phase 1, randomized, placebo-controlled first-in-human trial of Griffithsin formulated in a Carrageenan vaginal gel. PLoS One. 17, e0261775 (2022).","journal-title":"PLoS One"},{"key":"39062_CR16","first-page":"1029","volume":"330","author":"E Harris","year":"2023","unstructured":"Harris, E. One in 5 males worldwide has high-risk genital HPV. JAMA 330, 1029 (2023).","journal-title":"JAMA"},{"key":"39062_CR17","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.4103\/jcrt.JCRT_957_19","volume":"17","author":"SL Krishnappa","year":"2021","unstructured":"Krishnappa, S. L. et al. Salivary detection of high-risk human papillomavirus 16 in oral squamous cell carcinoma using polymerase chain reaction in the South Indian population. J. Cancer Res. Ther. 17, 1017\u20131024 (2021).","journal-title":"J. Cancer Res. Ther."},{"key":"39062_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/jpm12040594","volume":"12","author":"CS Cheng","year":"2022","unstructured":"Cheng, C. S., Ou, B. R. & Lung, F. D. Developing a biosensor-based immunoassay to detect HPV E6 oncoprotein in the saliva rinse fluid of oral cancer patients. J. Pers. Med. 12, 594 (2022).","journal-title":"J. Pers. Med."},{"key":"39062_CR19","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1093\/infdis\/jiaa621","volume":"224","author":"LE Markowitz","year":"2021","unstructured":"Markowitz, L. E. & Schiller, J. T. Human papillomavirus vaccines. J. Infect. Dis. 224, S367\u2013S378 (2021).","journal-title":"J. Infect. Dis."},{"key":"39062_CR20","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1080\/21645515.2018.1526559","volume":"15","author":"M Shew","year":"2019","unstructured":"Shew, M., Shew, M. L. & Bur, A. M. Otolaryngologists and their role in vaccination for prevention of HPV associated head & neck cancer. Hum. Vaccin Immunother. 15, 1929\u20131934 (2019).","journal-title":"Hum. Vaccin Immunother"},{"key":"39062_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-025-08910-6","volume":"641","author":"H Kiyono","year":"2025","unstructured":"Kiyono, H. & Ernst, P. B. Nasal vaccines for respiratory infections. Nature 641, 321\u2013330 (2025).","journal-title":"Nature"},{"key":"39062_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1473-3099(21)00648-4","volume":"22","author":"A Singanayagam","year":"2022","unstructured":"Singanayagam, A. et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect. Dis. 22, 183\u2013195 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"39062_CR23","doi-asserted-by":"publisher","first-page":"e4228","DOI":"10.1097\/MD.0000000000004228","volume":"95","author":"NP Nguyen","year":"2016","unstructured":"Nguyen, N. P. et al. Oral sex and oropharyngeal cancer: the role of the primary care physicians. Medicine 95, e4228 (2016).","journal-title":"Medicine"},{"key":"39062_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10147-016-1005-x","volume":"21","author":"D Sano","year":"2016","unstructured":"Sano, D. & Oridate, N. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma. Int. J. Clin. Oncol. 21, 819\u2013826 (2016).","journal-title":"Int. J. Clin. Oncol."},{"key":"39062_CR25","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.3390\/cancers13164089","volume":"13","author":"H Balaji","year":"2021","unstructured":"Balaji, H. et al. Causes and consequences of HPV integration in head and neck squamous cell carcinomas: State of the art. Cancers 13, 4089 (2021).","journal-title":"Cancers"},{"key":"39062_CR26","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.3390\/cancers14194623","volume":"14","author":"VL Porter","year":"2022","unstructured":"Porter, V. L. & Marra, M. A. The drivers, mechanisms, and consequences of genome instability in HPV-driven cancers. Cancers 14, 4623 (2022).","journal-title":"Cancers"},{"key":"39062_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/pathogens13010093","volume":"13","author":"B Wang","year":"2024","unstructured":"Wang, B. et al. The roles and interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in oral and gastrointestinal carcinogenesis: A narrative review. Pathogens 13, 93 (2024).","journal-title":"Pathogens"},{"key":"39062_CR28","doi-asserted-by":"publisher","first-page":"104925","DOI":"10.1016\/j.micinf.2021.104925","volume":"24","author":"S Singh","year":"2022","unstructured":"Singh, S. & Singh, A. K. Porphyromonas gingivalis in oral squamous cell carcinoma: A review. Microbes Infect. 24, 104925 (2022).","journal-title":"Microbes Infect."},{"key":"39062_CR29","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1186\/s12885-021-08903-4","volume":"21","author":"E McIlvanna","year":"2021","unstructured":"McIlvanna, E., Linden, G. J., Craig, S. G., Lundy, F. T. & James, J. A. Fusobacterium nucleatum and oral cancer: A critical review. BMC Cancer. 21, 1212 (2021).","journal-title":"BMC Cancer"},{"key":"39062_CR30","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00262-022-03348-5","volume":"72","author":"ZC Guo","year":"2023","unstructured":"Guo, Z. C., Jing, S. L., Jumatai, S. & Gong, Z. C. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment. Cancer Immunol. Immunother. 72, 1523\u20131539 (2023).","journal-title":"Cancer Immunol. Immunother"},{"key":"39062_CR31","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/microorganisms11092358","volume":"11","author":"P Pignatelli","year":"2023","unstructured":"Pignatelli, P., Nuccio, F., Piattelli, A. & Curia, M. C. The role of Fusobacterium nucleatum in oral and colorectal carcinogenesis. Microorganisms 11, 2358 (2023).","journal-title":"Microorganisms"},{"key":"39062_CR32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/s12903-024-04252-3","volume":"24","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. F. Nucleatum enhances oral squamous cell carcinoma proliferation via E-cadherin\/beta-catenin pathway. BMC Oral Health. 24, 518 (2024).","journal-title":"BMC Oral Health"},{"key":"39062_CR33","first-page":"436","volume":"5","author":"T Zhao","year":"2022","unstructured":"Zhao, T., Wang, X., Fu, L. & Yang, K. Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response. Cancer Drug Resist. 5, 436 (2022).","journal-title":"Cancer Drug Resist."},{"key":"39062_CR34","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/lary.29996","volume":"132","author":"S Christianto","year":"2022","unstructured":"Christianto, S., Li, K. Y., Huang, T. H. & Su, Y. X. The prognostic value of human papilloma virus infection in oral cavity squamous cell carcinoma: A meta-analysis. Laryngoscope 132, 1760\u20131770 (2022).","journal-title":"Laryngoscope"},{"key":"39062_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13643-023-02419-7","volume":"13","author":"S Li","year":"2024","unstructured":"Li, S. et al. Prognostic impact of oral microbiome on survival of malignancies: A systematic review and meta-analysis. Syst. Rev. 13, 41 (2024).","journal-title":"Syst. Rev."},{"key":"39062_CR36","doi-asserted-by":"publisher","first-page":"2105574","DOI":"10.1080\/20002297.2022.2105574","volume":"14","author":"K Hashimoto","year":"2022","unstructured":"Hashimoto, K. et al. Feasibility of oral microbiome profiles associated with oral squamous cell carcinoma. J. Oral Microbiol. 14, 2105574 (2022).","journal-title":"J. Oral Microbiol."},{"key":"39062_CR37","doi-asserted-by":"publisher","first-page":"e937126","DOI":"10.12659\/MSM.937126","volume":"28","author":"CX Li","year":"2022","unstructured":"Li, C. X., Su, Y., Gong, Z. C. & Liu, H. Porphyromonas gingivalis activation of tumor-associated macrophages via DOK3 promotes recurrence of oral squamous cell carcinoma. Med. Sci. Monit. 28, e937126\u2013e937121 (2022).","journal-title":"Med. Sci. Monit."},{"key":"39062_CR38","doi-asserted-by":"publisher","first-page":"1329057","DOI":"10.3389\/fcimb.2024.1329057","volume":"14","author":"J Makarewicz","year":"2024","unstructured":"Makarewicz, J. et al. Anti-cancer management of head and neck cancers and oral microbiome-what can we clinically obtain? Front. Cell. Infect. Microbiol. 14, 1329057 (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"39062_CR39","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/cncr.35458","volume":"130","author":"HM Bizuayehu","year":"2024","unstructured":"Bizuayehu, H. M. et al. Burden of 30 cancers among men: global statistics in 2022 and projections for 2050 using population-based estimates. Cancer 130, 3708\u20133723 (2024).","journal-title":"Cancer"},{"key":"39062_CR40","first-page":"42","volume":"11","author":"A Barsouk","year":"2023","unstructured":"Barsouk, A. et al. Risk Factors, and prevention of head and neck squamous cell carcinoma. Med. Sci. 11, 42 (2023).","journal-title":"Med. Sci."},{"key":"39062_CR41","first-page":"e245381","volume":"11","author":"K. A. B. Goddard","year":"2024","unstructured":"Goddard, K. A. B. et al. Estimation of cancer deaths averted from prevention, screening, and treatment efforts, 1975\u20132020. JAMA Oncol. 11, e245381 (2024).","journal-title":"JAMA Oncol."},{"key":"39062_CR42","unstructured":"NIH Research matters\u2013Prevention and screening drive drop in cancer deaths. (2025)."},{"key":"39062_CR43","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jama.2024.2396","volume":"331","author":"ITT Liu","year":"2024","unstructured":"Liu, I. T. T., Kesselheim, A. S. & Sheffer, E. R. Clinical benefits and regulatory outcome of cancer drugs receiving acceleratory approval. JAMA 331, 1471\u20131479 (2024).","journal-title":"JAMA"},{"key":"39062_CR44","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.joms.2013.06.006","volume":"71","author":"S. E. Chen","year":"2013","unstructured":"Chen, S. E., August, M. & Sadow, P. Diagnostic accuracy of incisional biopsy for head and neck Lesions. J. Oral Maxillofac. Surg. 71, e3. https:\/\/doi.org\/10.1016\/j.joms.2013.06.006 (2013).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"39062_CR45","doi-asserted-by":"publisher","first-page":"e0285214","DOI":"10.1371\/journal.pone.0285214","volume":"18","author":"PJ Brooks","year":"2023","unstructured":"Brooks, P. J., Malkin, E. Z., DeMichino, S. & Bratman, S. V. Isolation of salivary cell-free DNA for cancer detection. PLOS One. 18, e0285214 (2023).","journal-title":"PLOS One"},{"key":"39062_CR46","doi-asserted-by":"publisher","first-page":"1597086","DOI":"10.3389\/fonc.2025.1597086","volume":"15","author":"L Liu","year":"2025","unstructured":"Liu, L., Zhong, X., Zhong, Y. & Li, L. Recent advances in biomarker detection of oral squamous cell carcinoma. Front. Oncol. 15, 1597086. https:\/\/doi.org\/10.3389\/fonc.2025.1597086 (2025).","journal-title":"Front. Oncol."},{"issue":"1","key":"39062_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hed.70003","volume":"0","author":"M Bulfoni","year":"2025","unstructured":"Bulfoni, M. et al. Application of a Saliva-Based liquid biopsy for the detection of HPV in patients with oral cavity squamous cell carcinoma (OCSCC). Head Neck. 0 (1), 1\u20138. https:\/\/doi.org\/10.1002\/hed.70003 (2025).","journal-title":"Head Neck"},{"key":"39062_CR48","first-page":"107417","volume":"167","author":"M Araujo","year":"2025","unstructured":"Araujo, M. et al. Current status of Circulating tumor DNA and Circulating cell alterations in HPV-associated head and neck cancer. Oral Biol. 167, 107417 (2025).","journal-title":"Oral Biol."},{"key":"39062_CR49","doi-asserted-by":"publisher","first-page":"107262","DOI":"10.1016\/j.oraloncology.2025.107262","volume":"164","author":"S Chennareddy","year":"2025","unstructured":"Chennareddy, S. et al. Circulating tumor DNA in human papillomavirus-associated oropharyngeal cancer management: A systematic review. Oral Oncol. 164, 107262 (2025).","journal-title":"Oral Oncol."},{"key":"39062_CR50","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1001\/jama.2022.5542","volume":"327","author":"BN Rome","year":"2022","unstructured":"Rome, B. N., Egilman, A. C. & Kesselheim, A. S. Trends in prescription drug launch prices, 2008\u20132021. JAMA 327, 2145\u20132147 (2022).","journal-title":"JAMA"},{"key":"39062_CR51","doi-asserted-by":"crossref","unstructured":"Daniell, H. et al. Evaluation of biologics bioencapsulated in plant cells for FDA approval: safety and toxicology studies of ACE2\/Ang1-7. Pharmaceutics 17, 12 .","DOI":"10.3390\/pharmaceutics17010012"},{"key":"39062_CR52","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41440-025-02109-y","volume":"48","author":"N. Smruti","year":"2025","unstructured":"Smruti, N., Daniell, H., Hersch, E. & Margulies K. M. Clinical studies in myxomatous mitral valve disease dogs: Most prescribed acei inhibits ACE2 enzyme activity and ARB increases AngII pool in plasma. Hypertens. Res. 48, 1477\u20131490 (2025). 2024.","journal-title":"Hypertens. Res."},{"key":"39062_CR53","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1021\/acs.chemrev.4c00482","volume":"125","author":"S Ding","year":"2025","unstructured":"Ding, S. et al. Synthetic and biogenic materials for oral delivery of biologics: From bench to bedside. Chem. Rev. 125, 4009\u20134068 (2025).","journal-title":"Chem. Rev."},{"key":"39062_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12935-015-0206-0","volume":"15","author":"CY Xiao","year":"2015","unstructured":"Xiao, C. Y. et al. Observations on the expression of human papillomavirus major capsid protein in HeLa cells. Cancer Cell. Int. 15, 53 (2015).","journal-title":"Cancer Cell. Int."},{"key":"39062_CR55","doi-asserted-by":"publisher","unstructured":"Wang, M. B. et al. APG-157 monotherapy in patients with locally advanced squamous cell carcinoma of head and neck: A phase IIA, single arm trial. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.6087.","DOI":"10.1200\/JCO.2025.43.16_suppl.6087"},{"key":"39062_CR56","first-page":"djv086","volume":"07","author":"M Saraiya","year":"2015","unstructured":"Saraiya, M. et al. HPV typing of cancers workgroup. US assessment of HPV types in cancers: Implications for current and 9-valent HPV vaccines. J. Natl. Cancer Inst. 07, djv086 (2015).","journal-title":"J. Natl. Cancer Inst."},{"key":"39062_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ymthe.2024.12.008","volume":"33","author":"H Daniell","year":"2024","unstructured":"Daniell, H. et al. Debulking influenza and herpes simplex virus strains by a wide-spectrum anti-viral protein formulated in clinical grade chewing gum. Mol. Ther. 33, 184\u2013200 (2024).","journal-title":"Mol. Ther."},{"key":"39062_CR58","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.4103\/0974-8490.150528","volume":"7","author":"MV Pravin Charles","year":"2015","unstructured":"Pravin Charles, M. V., Kali, A. & Joseph, N. M. Performance of chromogenic media for Candida in rapid presumptive identification of Candida species from clinical materials. Pharmacognosy Res. 7, S69\u201373 (2015).","journal-title":"Pharmacognosy Res."},{"key":"39062_CR59","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1128\/jcm.10.6.844-849.1979","volume":"10","author":"CB Walker","year":"1979","unstructured":"Walker, C. B., Ratliff, D., Muller, D., Mandell, R. & Socransky, S. S. Medium for selective isolation of Fusobacterium nucleatum from human periodontal pockets. J. Clin. Microbiol. 10, 844\u2013849 (1979).","journal-title":"J. Clin. Microbiol."},{"key":"39062_CR60","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1099\/mic.0.2008\/022301-0","volume":"154","author":"E Llobet","year":"2008","unstructured":"Llobet, E., Tomas, J. M. & Bengoechea, J. A. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 154, 3877\u20133886 (2008).","journal-title":"Microbiology"},{"key":"39062_CR61","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1099\/mic.0.042978-0","volume":"156","author":"S Patrick","year":"2010","unstructured":"Patrick, S. et al. Twenty-eight divergent polysaccharide loci specifying within- and amongst-strain capsule diversity in three strains of bacteroides fragilis. Microbiology 156, 3255\u20133269 (2010).","journal-title":"Microbiology"},{"key":"39062_CR62","doi-asserted-by":"publisher","first-page":"9594","DOI":"10.3390\/ijms23179594","volume":"23","author":"ZD Mojdami","year":"2022","unstructured":"Mojdami, Z. D. et al. The effect of intensity-modulated radiotherapy to the head and neck region on the oral innate immune response and oral microbiome: A prospective cohort study of head and neck tumour patients. Int. J. Mol. Sci. 23, 9594 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"39062_CR63","unstructured":"Yantai, T. GRAS determination of Fava bean protein for use as an ingredient in human food (FULL Biotech Co., Ltd, 2019). https:\/\/www.cfsanappsexternal.fda.gov\/scripts\/fdcc\/index.cfm?set=GRASNotices&id=879&sort=GRN_No&order=DESC&startrow=1&type=basic&search=Fava%20Bean%20"},{"key":"39062_CR64","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1182\/blood-2017-09-806364","volume":"131","author":"V Gallo","year":"2018","unstructured":"Gallo, V. et al. No red blood cell damage and no hemolysis in G6PD-deficient subjects after ingestion of low vicine\/convicine vicia Faba seeds. Blood 131, 1621\u20131625 (2018).","journal-title":"Blood"},{"key":"39062_CR65","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1111\/pbi.13643","volume":"19","author":"Singh","year":"2021","unstructured":"Singh et al. Affordable oral health care: dental biofilm disruption using Chloroplast made enzymes with chewing gum delivery. Plant. Biotechnol. J. 19, 2133\u20132125 (2021).","journal-title":"Plant. Biotechnol. J."},{"key":"39062_CR66","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/pbi.14596","volume":"23","author":"I Fatima","year":"2025","unstructured":"Fatima, I., Wakade, G., Ahmed, N. & Daniell, H. Expression of endochitinase and exochitinase in lettuce chloroplasts increases plant biomass and kills fungal pathogen Candida albicans. Plant Biotechnol. J. 23, 1437\u20131451 (2025).","journal-title":"Plant Biotechnol. J."},{"key":"39062_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/pbi.70046","author":"I Fatima","year":"2025","unstructured":"Fatima, I., Wakade, G. & Daniell, H. Expression of mannanase and glucanases in lettuce chloroplasts and functional evaluation of enzyme cocktail against Candida albicans in oral cancer patient samples. Plant Biotechnol. J. https:\/\/doi.org\/10.1111\/pbi.70046 (2025).","journal-title":"Plant Biotechnol. J."},{"key":"39062_CR68","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/metabo14050277","volume":"14","author":"B Kashyap","year":"2024","unstructured":"Kashyap, B. & Kullaa, A. Salivary metabolites produced by oral microbes in oral diseases and oral squamous cell carcinoma: A review. Metabolites 14, 277 (2024).","journal-title":"Metabolites"},{"key":"39062_CR69","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1471-2180-12-144","volume":"12","author":"S Pushalkar","year":"2012","unstructured":"Pushalkar, S. et al. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol. 12, 144 (2012).","journal-title":"BMC Microbiol."},{"key":"39062_CR70","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/carcin\/bgaa062","volume":"42","author":"SC Su","year":"2021","unstructured":"Su, S. C. et al. Oral microbial dysbiosis and its performance in predicting oral cancer. Carcinogenesis 42, 127\u2013135 (2021).","journal-title":"Carcinogenesis"},{"key":"39062_CR71","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1158\/1055-9965.EPI-22-0642","volume":"31","author":"V Lorenzoni","year":"2022","unstructured":"Lorenzoni, V. et al. The current burden of oropharyngeal cancer: A global assessment based on GLOBOCAN 2020. Cancer Epidemiol. Biomark. Prev. 31, 2054\u20132062 (2022).","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39062-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39062-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39062-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:01:00Z","timestamp":1772460060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39062-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39062"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39062-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HD is a patentee in plant-based oral and topical drug delivery and was previously funded by Novo Nordisk, Bayer, Shire and Takeda. List of awarded and published patents are available in Google Scholar and Scholar GPS links below. However, there is no specific financial conflict related to this manuscript. All other authors declare that they have no competing interests. Scholar GPS:\n                      \n                      Scholar:\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Salivary samples from non-cancer and oral cancer patients were collected after obtaining approval from the IRB committee of the Veterans Administration of Greater Los Angeles Healthcare System (VAGLAHS), Los Angeles, California (IRB study #1615727). Informed consent approval was obtained from all cancer and non-cancer volunteers. The IRB at the University of Kansas School of Medicine approved the study (IRB# STUDY00001732). Informed consent was obtained from patients prior to commencement of all study activities. Samples collected from HNSCC patients and cancer-free participants were deidentified after obtaining written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"7886"}}